Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease

Simulation Study of Confounder-Selection Strategies

Maldonado, G., & Greenland, S. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116813 · Cited by 2,491 · see citing works

Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study

World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contarception (1995) · The Lancet · doi:10.1016/s0140-6736(95)91926-0 · Cited by 631 · see citing works

Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs

Inman, W. H. W., Vessey, M. P., Westerholm, B., & Engelund, A. (1970) · BMJ · doi:10.1136/bmj.2.5703.203 · Cited by 609 · see citing works

Oral Contraceptives and Cardiovascular Disease

Stadel, B. V. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109103051104 · Cited by 494 · see citing works

ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENT

Böttiger, L. E., Boman, G., Eklund, G., et al. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91550-0 · Cited by 396 · see citing works

Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic Disease

Gerstman, B. B., Piper, J. M., Tomita, D. K., Ferguson, W., Stadel, B. V., & Lundin, F. E. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115799 · Cited by 349 · see citing works

Case-Control Studies. Design, Conduct, Analysis.

ROSSITER, C. E., & Schlesselman, J. J. (1983) · Biometrics · doi:10.2307/2531131 · Cited by 314 · see citing works

Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.

Meade, T. W., Greenberg, G. M., & Thompson, S. G. (1980) · BMJ · doi:10.1136/bmj.280.6224.1157 · Cited by 310 · see citing works

Oral Contraceptives and Cardiovascular Disease

Stadel, B. V. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109173051205 · Cited by 233 · see citing works

The androgenicity of progestins

Darney, P. D. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80067-9 · Cited by 130 · see citing works

Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids

Stanczyk, F. Z., & Roy, S. (1990) · Contraception · doi:10.1016/0010-7824(90)90093-b · Cited by 122 · see citing works

Venous thromboembolism in relation to oral contraceptive use.

Helmrich, S. P., Rosenberg, L. A., Kaufman, D. W., Strom, B. L., & Shapiro, S. (1987) · PubMed · Cited by 111 · see citing works

VASECTOMY AND THE RISK OF PROSTATE CANCER

Rosenberg, L. A., Palmer, J. R., Zauber, A. G., et al. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115746 · Cited by 111 · see citing works

Clinical Pharmacokinetics of Contraceptive Steroids

Shenfield, G. M., & Griffin, J. M. (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199120010-00002 · Cited by 71 · see citing works

Exact Inference for Matched Case-Control Studies

Hirji, K. F., Mehta, C. R., & Patel, N. R. (1988) · Biometrics · doi:10.2307/2531592 · Cited by 71 · see citing works

A review of ‘once-a-month's combined injectable contraceptives

Newton, R., d’Arcangues, C., & Hall, P. E. (1994) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443619409027641 · Cited by 61 · see citing works

Classification and comparison of oral contraceptives containing new generation progestogens

Newton (1995) · Human Reproduction Update · doi:10.1093/humupd/1.3.231 · Cited by 57 · see citing works

Effect of levonorgestrel contraceptive implants, NORPLANT®, on blood coagulation

Shaaban, M. M., Elwan, S. I., El-Kabsh, M. Y., et al. (1984) · Contraception · doi:10.1016/0010-7824(84)90034-9 · Cited by 48 · see citing works

Androgenic effects of oral contraceptives: Implications for patient compliance

Jones, E. E. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80069-2 · Cited by 32 · see citing works

The effects of CTR-24, a biphasic oral contraceptive combination, compared to diane-35 in women with acne

Dieben, T. O. M., Vromans, L., Theeuwes, A., & Bennink, H. J. T. C. (1994) · Contraception · doi:10.1016/0010-7824(94)90024-8 · Cited by 28 · see citing works

Oral contraceptives and cardiovascular disease: An epidemiologic overview

Thorogood, M. (1993) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2630020103 · Cited by 26 · see citing works

Low‐dose combined oral contraceptives

Robinson, G. (1994) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1994.tb13578.x · Cited by 22 · see citing works

INVITED COMMENTARY: VASECTOMY AND PROSTATE CANCER

Guess, H. A. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115748 · Cited by 18 · see citing works

The effects on hemostasis of oral contraceptives containing desogestrel

Stubblefield, P. G. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90336-h · Cited by 12 · see citing works

A three-year evaluation of hemostatic function in Singaporean Norplant acceptors

Singh, K., Viegas, O. A. C., & Ratnam, S. S. (1990) · Advances in Contraception · doi:10.1007/bf01849484 · Cited by 6 · see citing works

Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study

World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contarception (1995) · The Lancet · doi:10.1016/s0140-6736(95)91926-0 · Cited by 631 · see citing works

Oral Contraceptives and the Risk of Myocardial Infarction

Tanis, B. C., van den Bosch, M. A. A. J., Kemmeren, J. M., Cats, V. M., Helmerhorst, F. M., Algra, A., van der Graaf, Y., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003216 · Cited by 367 · see citing works

Estrogen and thrombosis: a bench to bedside review

Abou-Ismail, M. Y., Citla Sridhar, D., & Nayak, L. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.05.008 · Cited by 261 · see citing works

A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception

Dragoman, M. V., Tepper, N. K., Fu, R., Curtis, K. M., Chou, R., & Gaffield, M. E. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12455 · Cited by 253 · see citing works

Mechanisms of estrogen-induced venous thromboembolism

Tchaikovski, S. N., & Rosing, J. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.01.045 · Cited by 219 · see citing works

Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial

Kemmeren, J. M., Algra, A., Meijers, J. C. M., Tans, G., Bouma, B. N., Curvers, J., Rosing, J., & Grobbee, D. E. (2004) · Blood · doi:10.1182/blood-2003-04-1285 · Cited by 157 · see citing works

Hormonal therapy for acne: why not as first line therapy? facts and controversies

Katsambas, A. D., & Dessinioti, C. (2010) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2009.03.006 · Cited by 101 · see citing works

Estrogen and thrombosis: controversies and common sense

DeLoughery, T. G. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9178-0 · Cited by 21 · see citing works

The 1995 Pill scare and its aftermath: lessons learnt

BHATHENA, R. K. (1998) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443619867335 · Cited by 6 · see citing works

Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

Jick, H., Jick, S. S., Myers, M. W., Vasilakis‐Scaramozza, C., & Gurewich, V. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91928-7 · Cited by 721 · see citing works

A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene- and monophasic desogestrel-containing oral contraceptives

Bruni, V., Croxatto, H. B., de la Cruz, J., et al. (2000) · Gynecological Endocrinology · doi:10.3109/09513590009167666 · Cited by 27 · see citing works

EFFECT OF DIFFERENT PROGESTAGENS IN LOW ESTROGEN ORAL-CONTRACEPTIVES ON VENOUS THROMBOEMBOLIC DISEASE

Farley, T., Meirik, O., CHANG, C., Marmot, M. G., & Poulter, N. R. (1995) · UCL Discovery (University College London) · Cited by 3 · see citing works

Both gestodene and desogestrel containing oral contraceptives reduce antipyrine clearance by impairing microsomal oxidative metabolism

Pazzucconi, F., Calabresi, L., Franceschini, G., et al. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)92069-u · Cited by 1 · see citing works

Clinical comparison of monophasic oral contraceptive preparations of gestodene/ethinyl estradiol and desogestrel/ethinyl estradiol. Latin American Oral Contraceptive Study Group.

(1994) · PubMed · Cited by 2 · see citing works